vs
Dogwood Therapeutics, Inc.（DWTX）与ReNew Energy Global plc（RNW）财务数据对比。点击上方公司名可切换其他公司
Dogwood Therapeutics, Inc.的季度营收约是ReNew Energy Global plc的1.3倍（$22.8K vs $17.0K）
Dogwood Therapeutics是一家处于临床阶段的生物技术企业，专注于研发针对罕见肾病、代谢类疾病及其他未被满足临床需求的靶向疗法，与全球医疗及科研伙伴合作推进创新候选药物管线，惠及各地患者。
ReNew Energy Global plc是印度可再生能源企业，总部位于古尔冈，是首家在纳斯达克上市的印度可再生能源公司，在印度10个邦运营超过150个项目，是印度可再生能源领域的代表性企业。
DWTX vs RNW — 直观对比
营收规模更大
DWTX
是对方的1.3倍
$17.0K
损益表 — Q1 FY2024 vs Q2 FY2023
| 指标 | | |
|---|---|---|
| 营收 | $22.8K | $17.0K |
| 净利润 | $-1.3M | — |
| 毛利率 | — | — |
| 营业利润率 | -5772.2% | — |
| 净利率 | -5672.2% | — |
| 营收同比 | -43.7% | — |
| 净利润同比 | 14.9% | — |
| 每股收益（稀释后） | $-1.68 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DWTXRNW
| Q1 24 | $22.8K | — | ||
| Q4 23 | $35.0K | — | ||
| Q3 23 | $39.2K | — | ||
| Q2 23 | $36.3K | — | ||
| Q1 23 | $40.4K | — | ||
| Q4 22 | $45.2K | — | ||
| Q3 22 | $16.6K | $17.0K | ||
| Q2 22 | $4.8K | — |
净利润DWTXRNW
| Q1 24 | $-1.3M | — | ||
| Q4 23 | $-1.1M | — | ||
| Q3 23 | $-1.2M | — | ||
| Q2 23 | $-1.4M | — | ||
| Q1 23 | $-1.5M | — | ||
| Q4 22 | $-2.0M | — | ||
| Q3 22 | $-2.6M | — | ||
| Q2 22 | $-3.7M | — |
营业利润率DWTXRNW
| Q1 24 | -5772.2% | — | ||
| Q4 23 | -3256.2% | — | ||
| Q3 23 | -3249.5% | — | ||
| Q2 23 | -4068.0% | — | ||
| Q1 23 | -3852.5% | — | ||
| Q4 22 | -4627.4% | — | ||
| Q3 22 | -15611.7% | — | ||
| Q2 22 | -76437.5% | — |
净利率DWTXRNW
| Q1 24 | -5672.2% | — | ||
| Q4 23 | -3156.2% | — | ||
| Q3 23 | -3149.5% | — | ||
| Q2 23 | -3968.0% | — | ||
| Q1 23 | -3752.5% | — | ||
| Q4 22 | -4527.4% | — | ||
| Q3 22 | -15511.7% | — | ||
| Q2 22 | -76337.5% | — |
每股收益（稀释后）DWTXRNW
| Q1 24 | $-1.68 | — | ||
| Q4 23 | $-5.27 | — | ||
| Q3 23 | $-1.62 | — | ||
| Q2 23 | $-0.08 | — | ||
| Q1 23 | $-0.08 | — | ||
| Q4 22 | $0.09 | — | ||
| Q3 22 | $-0.28 | — | ||
| Q2 22 | $-0.44 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7M | — |
| 总资产 | $3.2M | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DWTXRNW
| Q1 24 | $2.4M | — | ||
| Q4 23 | $3.3M | — | ||
| Q3 23 | $4.8M | — | ||
| Q2 23 | $4.6M | — | ||
| Q1 23 | $5.3M | — | ||
| Q4 22 | $7.0M | — | ||
| Q3 22 | $9.8M | — | ||
| Q2 22 | $7.7M | — |
股东权益DWTXRNW
| Q1 24 | $2.7M | — | ||
| Q4 23 | $3.8M | — | ||
| Q3 23 | $4.8M | — | ||
| Q2 23 | $4.7M | — | ||
| Q1 23 | $6.0M | — | ||
| Q4 22 | $7.3M | — | ||
| Q3 22 | $9.2M | — | ||
| Q2 22 | $7.1M | — |
总资产DWTXRNW
| Q1 24 | $3.2M | — | ||
| Q4 23 | $4.2M | — | ||
| Q3 23 | $5.2M | — | ||
| Q2 23 | $5.2M | — | ||
| Q1 23 | $6.5M | — | ||
| Q4 22 | $8.4M | — | ||
| Q3 22 | $10.9M | — | ||
| Q2 22 | $9.0M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-937.4K | $4.4K |
| 自由现金流经营现金流 - 资本支出 | — | $-23.6K |
| 自由现金流率自由现金流/营收 | — | -139.0% |
| 资本支出强度资本支出/营收 | — | 164.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DWTXRNW
| Q1 24 | $-937.4K | — | ||
| Q4 23 | $-1.5M | — | ||
| Q3 23 | $-960.5K | — | ||
| Q2 23 | $-742.4K | — | ||
| Q1 23 | $-1.7M | — | ||
| Q4 22 | $-2.7M | — | ||
| Q3 22 | $-2.5M | $4.4K | ||
| Q2 22 | $-3.7M | — |
自由现金流DWTXRNW
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — | ||
| Q3 22 | — | $-23.6K | ||
| Q2 22 | — | — |
自由现金流率DWTXRNW
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — | ||
| Q3 22 | — | -139.0% | ||
| Q2 22 | — | — |
资本支出强度DWTXRNW
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — | ||
| Q3 22 | — | 164.7% | ||
| Q2 22 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
